0      0

2020 ISPE Continuous Manufacturing Virtual Workshop


Continuous Manufacturing for Emergency Preparedness and Rapid Response: Accelerating Widespread Adoption


Jun 4, 2020 2:00pm ‐ Jun 4, 2020 3:30pm

Description

The onset of the COVID 19 pandemic has illustrated the importance of the FDA's desired state of a "maximally efficient, agile, flexible pharmaceutical manufacturing sector". Continuous manufacturing has the potential to rapidly respond to changes in demand due to local or global changes. Speakers in this session will discuss how government agencies, pharmacopeial organizations, and industry are working to advance continuous manufacturing and the potential of this technology to respond to the current situation and future challenges.

Moderator/Speaker(s):

  • Christine Moore, PhD, Global Head and Executive Director, GRACS CMC Policy, Merck & Co., Inc.

Speaker(s):

  • Stelios C. Tsinontides, PhD, FAIChE, Director, Office of Pharmaceutical Assessment, CDER/FDA
  • Atul Dubey, PhD, Director, Pharmaceutical Continuous Manufacturing, USP Reference Standards Labs
  • B. Frank Gupton, PhD, Floyd D. Gotttwald Professor & Chair, Chemical & Life Science Engineering, Virginia Commonwealth University
  • Anne Fischer, PhD, Programs Manager, Defense Science Office, Defense Advanced Research Projects Agency (DARPA)
  • Paul Collins, PhD, Senior Director, Small Molecule Design and Development, Eli Lilly and Company

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content